Log In
person
ImmunoGen Inc
IMGN
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Oncology Pharma |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
105.29M | 96.79% |
| Oncology Pharma |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
2.55M | 2.35% |
| Oncology Pharma |
Contract Research for Drug Manufacturers
These companies do contract services for biotech and pharmaceutical companies.
|
0.94M | 0.86% |
| keyboard_arrow_down |
Oncology Pharma
Pharmaceutical Patent Licensing
|
105.29M | 96.79% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Oncology Pharma
Branded Pharmaceuticals
|
2.55M | 2.35% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Oncology Pharma
Contract Research for Drug Manufacturers
|
0.94M | 0.86% |
| keyboard_arrow_right |
These companies do contract services for biotech and pharmaceutical companies.
|
||